Registration for a live webinar on 'Neuroleptic malignant syndrome' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this free, full length talk
Topics Covered
- The need to characterise SARS-CoV-2-specific T-cells from recovered patients
- Discovery of similar SARS-CoV-2-specific T-cells in healthy volunteers
- Possible reasons for presence of SARS-2-specific T-cells in healthy volunteers
- Differences in actions and behaviours of SARS-2-specific T-cells in patients versus volunteers
- Role of SARS-2-specific T-cells in conferring pre-existing immunity to COVID-19 (i.e. asymptomatic infections)
- Possible implications of the presence of such cells on disease progression
- Implications for vaccine development
Biography
Dr. Nina Le Bert is currently a Senior Research Fellow in the Emerging Infectious Diseases Programme of DUKE-NUS Medical School in Singapore. She earned her Master of Science degree at the Free University of Berlin in Germany, and her PhD from the University College London, UK, in 2011, working in the field of human innate and adaptive immunity. In 2014, she joined Professor Antonio Bertoletti’s lab, where she is investigating virus-specific B and T cell responses during Hepatitis B Virus infection to better understand their role in protection and/or liver pathology. Since the outbreak of the COVID19 pandemic, she is involved in studies of SARS-CoV-2 specific T cells.
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Le Bert, N. (2020, September 24). Presence and function of SARS-CoV-2-specific T-cells in recovered patients and healthy volunteers [Audio file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved October 12, 2024, from https://doi.org/10.69645/YFAJ5759.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Nina Le Bert has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Presence and function of SARS-CoV-2-specific T-cells in recovered patients and healthy volunteers
Other Talks in the Playlist: Interviews on Covid-19
Transcript
Quiz
Disclaimer: This quiz is intended for learning assessment purposes only and does not grant any certification or credit.
If you are interested in getting a certificate for watching the talk, follow the instructions in this talk's Accreditation Information (where available.)